Details for New Drug Application (NDA): 011028
✉ Email this page to a colleague
NDA 011028 describes HYDELTRASOL, which is a drug marketed by Merck and is included in two NDAs. Additional details are available on the HYDELTRASOL profile page.
The generic ingredient in HYDELTRASOL is prednisolone sodium phosphate. There are eighty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.
The generic ingredient in HYDELTRASOL is prednisolone sodium phosphate. There are eighty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.
Summary for 011028
| Tradename: | HYDELTRASOL |
| Applicant: | Merck |
| Ingredient: | prednisolone sodium phosphate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;OPHTHALMIC, OTIC | Strength | EQ 0.25% PHOSPHATE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
